VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
TNGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
TNGXTango Therapeutics, Inc.
$25.53$4.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTNGXQuarterly Cash Flow

Tango Therapeutics, Inc. (TNGX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Tango Therapeutics, Inc. (TNGX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

TNGX Cash Flow Statement

Quarterly statement

TNGX Cash Flow Statement

Tango Therapeutics, Inc. (TNGX) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-38.87M-44.36M-29.72M-30.95M-36.52M-41.7M-36.65M-33.39M-23.61M-37.86M-27.47M-31.14M-24.47M-34.91M-28.27M-19.61M-31.54M-29.66M-16.9M-21.49M
Operating CF Margin %----57.52%-1148.04%-773.31%-890.14%-287.67%-118.78%-585.03%-505.74%-290.11%-167.65%-605.39%-440.9%-283.4%-546.49%-515.2%-295.7%-316.69%
Operating CF Growth %-6.43%-6.39%18.91%7.3%-54.7%-10.14%-33.42%-7.24%3.54%-8.45%2.83%-58.76%22.4%-17.67%-67.23%8.76%-319.5%-117.92%6.42%-119.32%
Net Income-55.34M-45.51M-38.75M15.88M-38.85M-39.88M-37.67M-29.17M-25.55M-37.91M-30.76M-22.26M-20.71M-28.01M-29.06M-29.05M-24.86M-25.21M-22.05M-19.59M
Depreciation & Amortization425K463K479K555K625K622K620K622K632K625K617K613K604K581K570K417K312K309K256K225K
Stock-Based Compensation16.89M10.8M5.98M6.63M6.57M7.25M7.46M7.18M7.54M6.72M4.88M4.86M5.12M4.22M3.79M3.81M3.42M3.21M2.26M3.43M
Deferred Taxes00000000000000000000
Other Non-Cash Items24K-63K171K412K295K318K88K-245K-236K-456K-1.45M1.67M24K-12K417K584K335K415K404K309K
Working Capital Changes-866K-10.04M2.4M-54.43M-5.16M-10.02M-7.15M-11.78M-5.99M-6.83M-750K-16.02M-9.51M-11.69M-3.98M4.62M-10.75M-8.39M2.23M-5.87M
Change in Receivables00000000000002M00006M0
Change in Inventory00000000000000000000
Change in Payables-759K1.78M-1.23M-344K-880K1.63M-2.51M3.05M-2.77M1.04M-88K-1.96M-1.21M1.55M-1.04M4.49M-2M-359K365K-1.88M
Cash from Investing-445.97M9.63M-135.72M47.48M16.78M30.6M52.06M32.57M12.7M-11.2M33.85M-56.66M32.69M31.55M-12.61M15.23M35.49M-11.72M-45.21M-152.21M
Capital Expenditures00-222K-151K-624K-51K-124K-115K-320K-195K-226K-16K-664K-620K-1.04M-3.28M-1.81M-1.56M-696K-774K
CapEx % of Revenue---0.28%19.62%0.95%3.01%0.99%1.61%3.01%4.16%0.15%4.55%10.75%16.24%47.38%31.38%27.11%12.18%11.4%
Acquisitions20K2K000000000000000000
Investments--------------------
Other Investing00000000000000000000
Cash from Financing672.57M79.85M219.38M2.54M581K2K969K2.4M1.31M42.98M1.47M80.28M586K73K527K113K718K257K-120K327.78M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)672.66M80.38M219.41M2.54M581K000041.72M079.84M00000000
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-95K-537K-36K002K969K2.4M1.31M1.26M1.47M441K586K73K527K113K718K257K-120K327.78M
Net Change in Cash187.73M45.12M53.94M19.07M-19.16M-11.1M16.38M1.58M-9.6M-6.08M7.85M-7.52M8.8M-3.28M-40.34M-4.27M4.67M-41.13M-62.23M154.07M
Free Cash Flow-38.87M-44.36M-29.94M-31.1M-37.14M-41.75M-36.77M-33.51M-23.93M-38.05M-27.69M-31.15M-25.14M-35.53M-29.31M-22.89M-33.35M-31.23M-17.6M-22.27M
FCF Margin %----57.8%-1167.65%-774.26%-893.15%-288.66%-120.39%-588.04%-509.91%-290.26%-172.19%-616.15%-457.14%-330.78%-577.87%-542.31%-307.87%-328.1%
FCF Growth %-4.64%-6.26%18.58%7.17%-55.23%-9.71%-32.78%-7.56%4.81%-7.11%5.51%-36.09%24.62%-13.77%-66.54%-2.79%-331.98%-126.64%4.97%-120.04%
FCF per Share-0.26-0.31-0.26-0.28-0.34-0.38-0.34-0.31-0.22-0.35-0.29-0.32-0.28-0.40-0.33-0.26-0.38-0.36-0.20-0.32
FCF Conversion (FCF/Net Income)0.70x0.97x0.77x-1.95x0.94x1.05x0.97x1.14x0.92x1.00x0.89x1.40x1.18x1.25x0.97x0.68x1.27x1.18x0.77x1.10x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000